Mc Carthy Asset Management, Inc. Viatris Inc Transaction History

Mc Carthy Asset Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$9.95 - $12.27 $1,492 - $1,840	-150 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$13.25 - $15.13 $1,139 - $1,301	-86 Reduced 36.44%	150 $2,000
Q2 2021 Aug 05, 2021	SELL	$12.97 - $16.15 $1,297 - $1,614	-100 Reduced 29.76%	236 $3,000
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $1,127 - $1,538	83 Added 32.81%	336 $5,000
Q4 2020 Feb 01, 2021	BUY	$14.3 - $18.74 $3,617 - $4,741	253 New	253 $5,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.